2022 Q2 Form 10-Q Financial Statement
#000183449422000038 Filed on May 12, 2022
Income Statement
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
Revenue | $72.99M | $72.75M | $64.02M |
YoY Change | 6.59% | 7.29% | 18.72% |
Cost Of Revenue | $27.23M | $24.54M | $22.35M |
YoY Change | 29.0% | 25.99% | 39.45% |
Gross Profit | $45.76M | $48.22M | $41.67M |
YoY Change | -3.39% | -0.25% | 9.92% |
Gross Profit Margin | 62.7% | 66.27% | 65.08% |
Selling, General & Admin | $17.14M | $22.93M | $16.47M |
YoY Change | 38.02% | 8.19% | 72.65% |
% of Gross Profit | 37.46% | 47.56% | 39.53% |
Research & Development | $10.58M | $8.409M | $8.529M |
YoY Change | 45.1% | 20.37% | 66.91% |
% of Gross Profit | 23.11% | 17.44% | 20.47% |
Depreciation & Amortization | $13.47M | $600.0K | $12.80M |
YoY Change | 6.86% | 0.0% | -38.29% |
% of Gross Profit | 29.44% | 1.24% | 30.72% |
Operating Expenses | $36.76M | $33.62M | $33.91M |
YoY Change | 28.49% | 16.22% | 51.93% |
Operating Profit | $9.003M | $14.59M | $7.760M |
YoY Change | -52.01% | -24.79% | -50.22% |
Interest Expense | -$5.436M | $4.358M | -$5.542M |
YoY Change | -44.79% | -56.69% | -35.93% |
% of Operating Profit | -60.38% | 29.86% | -71.42% |
Other Income/Expense, Net | $216.0K | -$4.195M | $10.00K |
YoY Change | 2060.0% | -58.23% | -50.0% |
Pretax Income | $3.680M | $10.40M | -$3.346M |
YoY Change | -60.84% | 11.06% | -41.71% |
Income Tax | $1.508M | $2.920M | -$133.0K |
% Of Pretax Income | 40.98% | 28.08% | |
Net Earnings | $2.172M | $7.479M | -$3.213M |
YoY Change | -70.78% | 3.43% | -75.32% |
Net Earnings / Revenue | 2.98% | 10.28% | -5.02% |
Basic Earnings Per Share | $0.03 | $0.09 | |
Diluted Earnings Per Share | $26.42K | $0.09 | -$40.28K |
COMMON SHARES | |||
Basic Shares Outstanding | 80.53M shares | 79.97M shares | 80.48M shares |
Diluted Shares Outstanding | 82.22M shares | 82.23M shares |
Balance Sheet
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $100.3M | $146.7M | $113.6M |
YoY Change | 242.93% | 99.63% | |
Cash & Equivalents | $100.3M | $146.7M | $113.6M |
Short-Term Investments | |||
Other Short-Term Assets | $36.70M | $355.0K | $244.0K |
YoY Change | 276.51% | -95.71% | -42.86% |
Inventory | |||
Prepaid Expenses | $7.083M | $6.752M | |
Receivables | $36.58M | $32.16M | $24.91M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $173.5M | $188.9M | $148.0M |
YoY Change | 148.39% | 59.02% | 105.0% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $7.892M | $5.613M | $5.989M |
YoY Change | 11.08% | -20.95% | -21.2% |
Goodwill | $564.8M | $564.8M | |
YoY Change | 4.02% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $14.97M | $4.089M | $4.266M |
YoY Change | 176.88% | -53.83% | 23.65% |
Total Long-Term Assets | $885.4M | $866.3M | $877.9M |
YoY Change | -1.67% | -1.38% | -1.52% |
TOTAL ASSETS | |||
Total Short-Term Assets | $173.5M | $188.9M | $148.0M |
Total Long-Term Assets | $885.4M | $866.3M | $877.9M |
Total Assets | $1.059B | $1.055B | $1.026B |
YoY Change | 9.13% | 5.82% | 6.45% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.563M | $2.555M | $2.335M |
YoY Change | -34.88% | 15.61% | 3.46% |
Accrued Expenses | $28.02M | $25.87M | $24.67M |
YoY Change | 28.95% | 21.94% | 17.07% |
Deferred Revenue | $23.26M | $29.29M | $14.71M |
YoY Change | 12.37% | 35.26% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $3.362M | $3.256M | $2.139M |
YoY Change | 91.35% | -15.25% | -27.61% |
Total Short-Term Liabilities | $56.20M | $60.98M | $43.85M |
YoY Change | 14.41% | -26.83% | -71.3% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $424.4M | $424.7M | $425.4M |
YoY Change | -30.77% | -30.8% | -17.7% |
Other Long-Term Liabilities | $1.999M | $1.647M | $0.00 |
YoY Change | 242.88% | 161.01% | |
Total Long-Term Liabilities | $426.4M | $426.4M | $425.4M |
YoY Change | -30.51% | -30.6% | -17.7% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $56.20M | $60.98M | $43.85M |
Total Long-Term Liabilities | $426.4M | $426.4M | $425.4M |
Total Liabilities | $482.6M | $487.3M | $469.6M |
YoY Change | -27.18% | -30.15% | -29.93% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$32.87M | -$40.35M | |
YoY Change | 33.01% | ||
Common Stock | $600.7M | $596.6M | |
YoY Change | 15162.98% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $576.3M | $567.9M | $556.3M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.059B | $1.055B | $1.026B |
YoY Change | 9.13% | 5.82% | 6.45% |
Cashflow Statement
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $2.172M | $7.479M | -$3.213M |
YoY Change | -70.78% | 3.43% | -75.32% |
Depreciation, Depletion And Amortization | $13.47M | $600.0K | $12.80M |
YoY Change | 6.86% | 0.0% | -38.29% |
Cash From Operating Activities | $12.81M | $34.86M | $20.82M |
YoY Change | -39.62% | 21.49% | -43.97% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.618M | $419.0K | -$1.467M |
YoY Change | 52.21% | 71.02% | -52.37% |
Acquisitions | $0.00 | ||
YoY Change | -100.0% | ||
Other Investing Activities | -$53.06M | $0.00 | $815.0K |
YoY Change | 48.49% | -100.0% | -100.75% |
Cash From Investing Activities | -$55.68M | -$1.941M | -$652.0K |
YoY Change | 48.66% | -97.76% | -99.41% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -3.617M | $179.0K | 445.0K |
YoY Change | -87.06% | -99.81% | -108.24% |
NET CHANGE | |||
Cash From Operating Activities | 12.81M | $34.86M | 20.82M |
Cash From Investing Activities | -55.68M | -$1.941M | -652.0K |
Cash From Financing Activities | -3.617M | $179.0K | 445.0K |
Net Change In Cash | -46.49M | $33.10M | 20.62M |
YoY Change | 5.19% | -7.46% | -125.97% |
FREE CASH FLOW | |||
Cash From Operating Activities | $12.81M | $34.86M | $20.82M |
Capital Expenditures | -$2.618M | $419.0K | -$1.467M |
Free Cash Flow | $15.43M | $34.44M | $22.29M |
YoY Change | -32.74% | 21.06% | -44.61% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2022Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001834494 | |
CY2022Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.5 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent | |
CY2022Q1 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent | |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent | |
CY2022Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2022Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2022Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-03-31 | |
CY2022Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022Q1 | dei |
Entity File Number
EntityFileNumber
|
001-40680 | |
CY2022Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
MeridianLink, Inc. | |
CY2022Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-4844620 | |
CY2022Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3560 Hyland Avenue | |
CY2022Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 200 | |
CY2022Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Costa Mesa | |
CY2022Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2022Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92626 | |
CY2022Q1 | dei |
City Area Code
CityAreaCode
|
714 | |
CY2022Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
708-6950 | |
CY2022Q1 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.001 per share | |
CY2022Q1 | dei |
Trading Symbol
TradingSymbol
|
MLNK | |
CY2022Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NYSE | |
CY2022Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2022Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
80531780 | shares |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
146746000 | USD |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
113645000 | USD |
CY2022Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
32160000 | USD |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
24913000 | USD |
CY2022Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
10010000 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
9398000 | USD |
CY2022Q1 | us-gaap |
Assets Current
AssetsCurrent
|
188916000 | USD |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
147956000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5613000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5989000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2311000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
287854000 | USD |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
298597000 | USD |
CY2022Q1 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1608000 | USD |
CY2021Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
4286000 | USD |
CY2022Q1 | us-gaap |
Goodwill
Goodwill
|
564799000 | USD |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
564799000 | USD |
CY2022Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4089000 | USD |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4266000 | USD |
CY2022Q1 | us-gaap |
Assets
Assets
|
1055190000 | USD |
CY2021Q4 | us-gaap |
Assets
Assets
|
1025893000 | USD |
CY2022Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2555000 | USD |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2335000 | USD |
CY2022Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
25872000 | USD |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
24667000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
29293000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
14707000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3256000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2139000 | USD |
CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
60976000 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
43848000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
424712000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
425371000 | USD |
CY2022Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
0 | USD |
CY2021Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
396000 | USD |
CY2022Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1647000 | USD |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
487335000 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
469615000 | USD |
CY2022Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2022Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
79734984 | shares |
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
80325231 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
80325231 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
79734984 | shares |
CY2022Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
120000 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
596542000 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-32873000 | USD |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
88000 | USD |
CY2022Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
600608000 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-40352000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
567855000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
556278000 | USD |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1055190000 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1025893000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
72754000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
67811000 | USD |
CY2022Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
21104000 | USD |
CY2021Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
16614000 | USD |
CY2022Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
3434000 | USD |
CY2021Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
2862000 | USD |
CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
24538000 | USD |
CY2021Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
19476000 | USD |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
48216000 | USD |
CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
48335000 | USD |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18187000 | USD |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
17595000 | USD |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8409000 | USD |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6986000 | USD |
CY2022Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
4743000 | USD |
CY2021Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
3599000 | USD |
CY2022Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
2283000 | USD |
CY2021Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
750000 | USD |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
33622000 | USD |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
28930000 | USD |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
14594000 | USD |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
19405000 | USD |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
163000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-1701000 | USD |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
20000 | USD |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
4358000 | USD |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
10062000 | USD |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-4195000 | USD |
CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-10042000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
10399000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
9363000 | USD |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2920000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2132000 | USD |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7479000 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7231000 | USD |
CY2022Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
0 | USD |
CY2021Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
8932000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
7479000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
7479000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1701000 | USD |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.09 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
79974071 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
51551231 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82228936 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
51551231 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
556278000 | USD |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
179000 | USD |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3887000 | USD |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7479000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
567855000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-26429000 | USD |
CY2021Q1 | mlnk |
Adjustment To Accumulated Deficit
AdjustmentToAccumulatedDeficit
|
12000 | USD |
CY2021Q1 | mlnk |
Share Based Compensation By Share Based Award Vesting Of Equity Units Value
ShareBasedCompensationByShareBasedAwardVestingOfEquityUnitsValue
|
38000 | USD |
CY2021Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
1887000 | USD |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
643000 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7231000 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-20416000 | USD |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7479000 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
7231000 | USD |
CY2022Q1 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
12905000 | USD |
CY2021Q1 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
12351000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
484000 | USD |
CY2021Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1072000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3808000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
643000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-135000 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-76000 | USD |
CY2022Q1 | mlnk |
Gain Loss On Sublease Liability
GainLossOnSubleaseLiability
|
0 | USD |
CY2021Q1 | mlnk |
Gain Loss On Sublease Liability
GainLossOnSubleaseLiability
|
-384000 | USD |
CY2022Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
2679000 | USD |
CY2021Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
2064000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7248000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
8958000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
460000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1637000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
301000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
195000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
194000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
107000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
14586000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
15195000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
0 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-26000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
34863000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
28697000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
85646000 | USD |
CY2022Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2022Q1 | us-gaap |
Payments For Software
PaymentsForSoftware
|
1522000 | USD |
CY2021Q1 | us-gaap |
Payments For Software
PaymentsForSoftware
|
804000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
419000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
245000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1941000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-86695000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
179000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
|
0 | USD |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
|
100000000 | USD |
CY2022Q1 | us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
0 | USD |
CY2021Q1 | us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
1295000 | USD |
CY2022Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2021Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
1970000 | USD |
CY2022Q1 | mlnk |
Payment Of Preferred Dividend
PaymentOfPreferredDividend
|
0 | USD |
CY2021Q1 | mlnk |
Payment Of Preferred Dividend
PaymentOfPreferredDividend
|
12000 | USD |
CY2021Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1013000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
179000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
93769000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
33101000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
35771000 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
113645000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
39881000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
146746000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
75652000 | USD |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
146746000 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
73510000 | USD |
CY2022Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
0 | USD |
CY2021Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
2142000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
146746000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
75652000 | USD |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3869000 | USD |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
8973000 | USD |
CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
44000 | USD |
CY2021Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
11000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
3372000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
0 | USD |
CY2022Q1 | mlnk |
Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
|
2627000 | USD |
CY2021Q1 | mlnk |
Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
|
0 | USD |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
79000 | USD |
CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
0 | USD |
CY2022Q1 | mlnk |
Share Based Payment Arrangement Vested
ShareBasedPaymentArrangementVested
|
32000 | USD |
CY2021Q1 | mlnk |
Share Based Payment Arrangement Vested
ShareBasedPaymentArrangementVested
|
0 | USD |
CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | USD |
CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
13000 | USD |
CY2022Q1 | mlnk |
Deferred Offering Costs Incurred But Not Paid Included In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsIncurredButNotPaidIncludedInAccountsPayableAndAccruedLiabilities
|
0 | USD |
CY2021Q1 | mlnk |
Deferred Offering Costs Incurred But Not Paid Included In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsIncurredButNotPaidIncludedInAccountsPayableAndAccruedLiabilities
|
222000 | USD |
CY2022Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
Organization and Description of Business<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MeridianLink, Inc., and its wholly-owned subsidiaries, (collectively the “Company”) provides secure, cloud-based digital solutions that transform the ways in which traditional and emerging financial services providers engage with account holders and end users. The Company sells its solutions to financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service (“SaaS”) model under which its customers pay subscription fees for the use of the Company’s solutions. The Company is controlled by its majority stockholder, which is represented by various investment funds of Thoma Bravo UBP, LLC and its affiliates (“Thoma Bravo”). The Company is headquartered in Costa Mesa, California.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Conversion</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to July 27, 2021, the Company operated as a Delaware limited liability company under the name Project Angel Parent, LLC (“Parent”), which directly and indirectly held all the equity interests in its operating subsidiaries. On May 31, 2018, a subsidiary of Parent acquired all the outstanding common stock of MeridianLink, Inc. (“MeridianLink”). Under the terms of the Amended and Restated Limited Liability Company Operating Agreement (“Agreement”), dated as of May 31, 2018, of Parent, the members were not obligated for debt, liabilities, contracts or other obligations of Parent. Profits and losses were allocated to members as defined in the Agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2021, prior to the effectiveness of the registration statement for the Company’s initial public offering, MeridianLink, the then operating company and the indirect wholly owned subsidiary of Project Angel Parent, LLC, changed its name to ML California Sub, Inc, and Project Angel Parent, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to MeridianLink, Inc. As a result of the corporate conversion, MeridianLink, Inc. succeeded to all property and assets and debts and obligations of Project Angel Parent, LLC. Effective July 27, 2021, MeridianLink, Inc. is governed by its certificate of incorporation filed with the Delaware Secretary of State and its bylaws.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon its conversion into a corporation, the Company converted each of its outstanding Class A preferred units (“Class A Units”) into a number of shares of common stock equal to the result of the accrued preferred return price per Class A Unit divided by the per share of common stock conversion price determined by the board of directors to be $25.50. The preferred return price for each Class A Unit was equal to the future value of $1,000 at a 9% interest rate compounded quarterly over the time passed since the issuance of such unit. Upon the Company’s conversion into a corporation, the outstanding Class A Units converted into an aggregate of 16,607,235 shares of common stock and were reclassified in to permanent equity. Additionally, all the outstanding Class B common units (“Class B Units”) converted into an aggregate of 53,646,668 shares of common stock on a one-for-one basis. At the time of the corporate conversion there were 1,533,763 of such shares that remained subject to future vesting and were not included in the outstanding shares. Following the Corporate Conversion, there were no units of Class A Units outstanding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the events described in the preceding two paragraphs are collectively referred to as the “Corporate Conversion.”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering and Reverse Stock Split</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Company completed its initial public offering (“IPO”) through an underwritten sale of 13.2 million shares of its common stock, of which 10.0 million newly issued shares were sold by the Company at a price to the public of $26.00 per share. The Company received net proceeds of approximately $242.1 million after deducting approximately $17.9 million in underwriting discounts, commissions, and offering-related expenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPO also included the sale of 3.2 million shares of our common stock by the selling stockholders. The Company did not receive any proceeds from the sale of common stock by the selling stockholders. Additionally, the selling stockholders granted the underwriters an option, exercisable for 30 days after the effective date of the Prospectus, to purchase up to 2.0 million additional shares of common stock. The option was exercised for 1.2 million additional shares on August 26, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the listing of the Company’s common stock on the New York Stock Exchange (the “NYSE”), the Company entered into indemnification agreements with its directors and certain officers and employees that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or services as directors, officers, or employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the IPO, on July 16, 2021, the Company effected a 1-for-2 reverse unit split of the Company’s Class B Units, whereby every two Class B Units converted into one Class B Unit. All Class B Unit and per unit information included in the accompanying condensed consolidated financial statements have been adjusted to reflect this reverse unit split for all periods presented. Following the Corporate Conversion, there were no units of Class B Units outstanding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization characterized the novel coronavirus (“COVID-19”) outbreak as a pandemic. To date, the Company has not experienced any significant effects on its partners or bad debts related to customer receivables as a result of the COVID-19 pandemic.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief and Economic Security (“CARES”) Act, enacted in March 2020 in response to the pandemic.. The CARES Act did not have a material impact on the Company's income tax provision in 2021 and 2022. As of March 31, 2022, the Company deferred $0.8 million of payments related to employer social security taxes, which will be due on December 31, 2022 and are included in accrued liabilities on the Company’s condensed consolidated balance sheets.</span></div>The Company continues to evaluate market and economic conditions surrounding the COVID-19 pandemic as well as current and potential impacts on the Company’s business and financial position. Due to the unpredictable circumstances, however, the Company cannot reasonably estimate such impacts on future financial results at this time. | |
CY2021Q3 | mlnk |
Conversion Of Stock Conversion Price
ConversionOfStockConversionPrice
|
25.50 | |
CY2021Q3 | mlnk |
Temporary Equity Future Value
TemporaryEquityFutureValue
|
1000 | USD |
CY2021Q3 | mlnk |
Temporary Equity Compound Interest Rate
TemporaryEquityCompoundInterestRate
|
0.09 | |
CY2021Q3 | mlnk |
Conversion Of Stock Shares Converted Nonvested
ConversionOfStockSharesConvertedNonvested
|
1533763 | shares |
CY2021Q3 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
13200000 | shares |
CY2021Q3 | mlnk |
Stock Shares Tendered For Sale By The Existing Stockholders
StockSharesTenderedForSaleByTheExistingStockholders
|
3200000 | shares |
CY2021Q3 | mlnk |
Number Of Days Granted To Underwriters To Purchase Additional Shares Of Common Stock
NumberOfDaysGrantedToUnderwritersToPurchaseAdditionalSharesOfCommonStock
|
P30D | |
CY2021Q3 | mlnk |
Stock Shares Partially Tendered For Sale By The Existing Stockholders
StockSharesPartiallyTenderedForSaleByTheExistingStockholders
|
2000000 | shares |
CY2021Q3 | mlnk |
Stock Shares Tendered For Sale By The Existing Stockholders
StockSharesTenderedForSaleByTheExistingStockholders
|
1200000 | shares |
CY2022Q1 | mlnk |
Cares Act Deferred Social Security Tax Payments Employer And Add Cares Act
CARESActDeferredSocialSecurityTaxPaymentsEmployerAndAddCARESAct
|
800000 | USD |
CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations, variable consideration, and other revenue items requiring significant judgment; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of property and equipment and long-lived intangible assets; impairment of goodwill and long-lived assets; the determination of the incremental borrowing rate used for operating lease liabilities; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on</span><span style="color:#332f2f;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.</span></div> | |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2600000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3400000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
72754000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
67811000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
72754000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
67811000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
14707000 | USD |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
10873000 | USD |
CY2022Q1 | mlnk |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
87340000 | USD |
CY2021Q1 | mlnk |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
83006000 | USD |
CY2022Q1 | mlnk |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
72754000 | USD |
CY2021Q1 | mlnk |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
67811000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
29293000 | USD |
CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
26068000 | USD |
CY2021Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
5835000 | USD |
CY2020Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
3207000 | USD |
CY2022Q1 | mlnk |
Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
|
607000 | USD |
CY2021Q1 | mlnk |
Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
|
992000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
554000 | USD |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
259000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
5888000 | USD |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
3940000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2572000 | USD |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
1572000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
|
3316000 | USD |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
|
2368000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
5888000 | USD |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
3940000 | USD |
CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
100000 | USD |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
200000 | USD |
CY2022Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
7083000 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
6752000 | USD |
CY2022Q1 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2572000 | USD |
CY2021Q4 | us-gaap |
Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
|
2402000 | USD |
CY2022Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
355000 | USD |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
244000 | USD |
CY2022Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
10010000 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
9398000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12477000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12367000 | USD |
CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6864000 | USD |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6378000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5613000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5989000 | USD |
CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
600000 | USD |
CY2021Q1 | us-gaap |
Depreciation
Depreciation
|
600000 | USD |
CY2022Q1 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
12503000 | USD |
CY2022Q1 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
5162000 | USD |
CY2022Q1 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
7341000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
440678000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
152824000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
287854000 | USD |
CY2021Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
10902000 | USD |
CY2021Q4 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
4254000 | USD |
CY2021Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
6648000 | USD |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
439077000 | USD |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
140480000 | USD |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
298597000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
12344000 | USD |
CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11767000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
37027000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
47542000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
45632000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
40474000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
37514000 | USD |
CY2022Q1 | mlnk |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
79665000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
287854000 | USD |
CY2022Q1 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
2021000 | USD |
CY2021Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
6708000 | USD |
CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
7758000 | USD |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
8522000 | USD |
CY2022Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2939000 | USD |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2939000 | USD |
CY2022Q1 | mlnk |
Accrued Costs Of Revenues
AccruedCostsOfRevenues
|
4570000 | USD |
CY2021Q4 | mlnk |
Accrued Costs Of Revenues
AccruedCostsOfRevenues
|
2217000 | USD |
CY2022Q1 | mlnk |
Accrued Operating Costs
AccruedOperatingCosts
|
2170000 | USD |
CY2021Q4 | mlnk |
Accrued Operating Costs
AccruedOperatingCosts
|
2099000 | USD |
CY2022Q1 | mlnk |
Business Combination Accrued Acquisition Related Costs Current
BusinessCombinationAccruedAcquisitionRelatedCostsCurrent
|
1755000 | USD |
CY2021Q4 | mlnk |
Business Combination Accrued Acquisition Related Costs Current
BusinessCombinationAccruedAcquisitionRelatedCostsCurrent
|
0 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1337000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
233000 | USD |
CY2022Q1 | mlnk |
Accrued User Conference Costs Current
AccruedUserConferenceCostsCurrent
|
1247000 | USD |
CY2021Q4 | mlnk |
Accrued User Conference Costs Current
AccruedUserConferenceCostsCurrent
|
170000 | USD |
CY2022Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2075000 | USD |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1779000 | USD |
CY2022Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
25872000 | USD |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
24667000 | USD |
CY2022Q1 | us-gaap |
Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
|
227000 | USD |
CY2022Q1 | us-gaap |
Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
|
375000 | USD |
CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | USD |
CY2022Q1 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
395000 | USD |
CY2022Q1 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
11872000 | USD |
CY2022Q1 | us-gaap |
Purchase Obligation
PurchaseObligation
|
12869000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y | |
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.050 | |
CY2022Q1 | mlnk |
Lessee Operating Lease Monthly Payments
LesseeOperatingLeaseMonthlyPayments
|
100000 | USD |
CY2021Q1 | mlnk |
Lessee Operating Lease Monthly Payments
LesseeOperatingLeaseMonthlyPayments
|
100000 | USD |
CY2021Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
100000 | USD |
CY2022Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
100000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-100000 | USD |
CY2022Q1 | us-gaap |
Lease Cost
LeaseCost
|
347000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
400000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2311000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1337000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1632000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2969000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1205000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
750000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
676000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
320000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
244000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3256000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
3195000 | USD |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
226000 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2969000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
|
293000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1318000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
753000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
722000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
319000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
244000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
|
293000 | USD |
CY2021Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3356000 | USD |
CY2021Q1 | us-gaap |
Lease Cost
LeaseCost
|
512000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
200000 | USD |
CY2022Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
435000000 | USD |
CY2021Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
435000000 | USD |
CY2022Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
7032000 | USD |
CY2021Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
7490000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
427968000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
427510000 | USD |
CY2022Q1 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
1094000 | USD |
CY2021Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
1124000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2139000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
424712000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
425371000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
500000 | USD |
CY2021Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1100000 | USD |
CY2022Q1 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
3900000 | USD |
CY2021Q1 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
9000000 | USD |
CY2022Q1 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
7600000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
3263000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
4350000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
4350000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
4350000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
4350000 | USD |
CY2022Q1 | mlnk |
Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
|
414337000 | USD |
CY2022Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
435000000 | USD |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4256812 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.05 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y5M8D | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
42429000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
28033 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
18.76 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
28909 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
6.19 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
123054 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
18.87 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4132882 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
12.96 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y2M8D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
31643537000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
4132882 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
12.96 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y2M8D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
31643537000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2328904 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
6.38 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y6M29D | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
27360724000 | USD |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1500000 | USD |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1100000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
400000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
17700000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
968809 | shares |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3808000 | USD |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
643000 | USD |
CY2022Q1 | us-gaap |
Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
|
100000 | USD |
CY2021Q1 | us-gaap |
Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
|
0 | USD |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.28 | |
CY2021Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.22 | |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
2400000 | USD |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1900000 | USD |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
CY2022Q1 | mlnk |
Number Of Related Party Properties Leased
NumberOfRelatedPartyPropertiesLeased
|
1 | Property |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
7479000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
7479000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1701000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-1701000 | USD |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
79974071 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
51551231 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82228936 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
51551231 | shares |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.09 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2351017 | shares |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5284468 | shares |